540359
PARMAX
Start SIP
Invest Now
Start SIP in PARMAX
Parmax Pharma live price: ₹32.72. It opened at ₹33 vs previous close ₹32; intraday high/low: ₹33/₹31. The 50 & 200 DMA stand at ₹32.94/₹35.17.
Parmax Pharma Performance
- Low
- ₹31
- High
- ₹33
- 52 Week Low
- ₹28
- 52 Week High
- ₹55
- Open Price₹33
- Previous Close₹32
- Volume173
- 50 DMA₹32.94
- 100 DMA₹33.62
- 200 DMA₹35.17
Investment Returns
- Over 1 Month -2.18%
- Over 3 Month -5.84%
- Over 6 Month -8.5%
- Over 1 Year -21.16%
Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!
Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -2.4
- PEG Ratio
- 0
- Market Cap Cr
- 12
- P/B Ratio
- -2
- Average True Range
- 2.68
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.56
- RSI
- 50.64
- MFI
- 46.63
Parmax Pharma Financials
Parmax Pharma Technicals
EMA & SMA
Current Price
₹32.72
+
0.29
(0.89%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹32.35
- 50 Day
- ₹32.94
- 100 Day
- ₹33.62
- 200 Day
- ₹35.17
Resistance and Support
32.16
- R3 35.55
- R2 34.23
- R1 33.48
- S1 31.41
- S2 30.09
- S3 29.34
Parmax Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Parmax Pharma F&O
About Parmax Pharma
- NSE Symbol
- PARMAX
- BSE Symbol
- 540359
- Managing Director
- Dr. Umang Alkesh Gosalia
- ISIN
- INE240T01014
Similar Stocks to Parmax Pharma
Parmax Pharma FAQs
Parmax Pharma share price is ₹32 As on 07 March, 2026 | 02:46
The Market Cap of Parmax Pharma is ₹12.2 Cr As on 07 March, 2026 | 02:46
The P/E ratio of Parmax Pharma is -2.4 As on 07 March, 2026 | 02:46
The PB ratio of Parmax Pharma is -2 As on 07 March, 2026 | 02:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.